v3.26.1
Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($)
Dec. 31, 2025
Dec. 31, 2024
Deferred tax assets:    
Deferred Compensation $ 105,500
Stock Comp Expense - NQSO 215,317 226,819
Charitable Contribution 2,628
Goodwill and Intangibles 347,114
Right of Use Liability 571,460 638,395
Restricted Stock Unit 76,805 60,408
Investment in HRCFG 162,851 127,365
Investment in Bloom Partnership 109,388 127,780
Investment in NAYA Therapeutics 648,427
IRC Sec. 174 Capitalization 103,191
Federal NOL Carryforwards 9,129,631 10,023,354
State NOL DTA, net of Fed Ben 1,599,258 1,597,307
Deferred Revenue 189,758 158,334
Gross deferred tax assets 12,401,582 13,171,081
Deferred tax liabilities:    
Fixed Assets (35,751) (38,163)
Goodwill and Intangibles (3,826,456)
Investment in NAYA Therapeutics (648,427)
Unrealized Gain/Loss on Fair Value (546,625)
Right of Use Asset (530,379) (600,308)
Gross deferred tax liability (1,761,182) (4,464,927)
Less: valuation allowance (10,640,400) (8,869,269)
Net deferred tax liability $ 163,115